Jefferies sidelined on Teva
(Reuters) -Israeli drugmaker Teva Pharmaceutical Industries (NYSE:TEVA) Ltd said there was sufficient participation from U.S. states and local authorities to move forward with its...
By Shawana Alleyne-Morris and Nancy Lapid (Reuters) - The annual number of new Parkinson's disease diagnoses in the United States is likely 50% higher than estimated, based on a...
Biotechnology stocks represent companies that research, develop or market healthcare-related therapies or products. They typically use living organisms, biological systems, or...
Warren Buffett, the widely-followed "Oracle of Omaha" who founded, and is currently chairman and CEO of Berkshire Hathaway (NYSE:BRKa) (NYSE:BRKb), is one of the US's most...
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) shares ended the last trading session 7.5% higher at $11.53. The jump came on an impressive volume with a higher-than-average number...
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
|Average||10.00 (-7.06% Downside)|
|No. of Analysts||10|